Company intelligence / Profile preview

AnthroTronix

Silver Spring, Maryland, United Statesanthrotronix.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

AnthroTronix has developed DANA, the first FDA-cleared mobile app for cognitive assessment used clinically and by the Department of Defense. The company also develops wearable devices like AcceleGlove for gesture recognition in rehabilitation. Clinical studies include digital health interventions to monitor caregiver stress/cognition in Alzheimer’s care.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceMobile health software platformWearable technologyRobotic system (for therapy/rehabilitation)
Industry: Digital Health Medical Devices

Partnerships

Cambridge Cognition (distribution agreement for DANA in US/EU)Mindoula Health/BrightFocus Foundation/Geoffrey Beene Foundation Alzheimer’s Initiative (“Health-eBrain” study on caregivers)

Beyond the preview

Go deeper on AnthroTronix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnthroTronix.

Explore the full profile